Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,976 | Dovepress* | 8,470+ | 855 | 9,325 | |
PubMed Central* | 506 | 157 | 663 | ||
Totals | 8,976 | 1,012 | 9,988 | ||
*Since 6 October 2017 |
View citations on PubMed Central and Google Scholar